NCT05753150View on ClinicalTrials.gov

Operational Feasibility of Appropriate Plasmodium Vivax Radical Cure After G6PD Testing in Thailand

CompletedOBSERVATIONAL
Enrollment

187

Participants

Timeline

Start Date

May 23, 2022

Primary Completion Date

August 31, 2023

Study Completion Date

October 1, 2023

Conditions
Malaria, VivaxG6PD Deficiency
Interventions
DRUG

Tafenoquine

Tafenoquine 300 mg (2x150 mg tablets)

DRUG

Primaquine

Daily primaquine adjusted by weight (0.25 mg/kg/day for 14 days)

DRUG

Primaquine

Weekly primaquine adjusted by weight (0.75mg/kg/week for 8 weeks)

Trial Locations (9)

58110

District Hospital, Mae Sariang

Malaria Clinic, Mae Sariang

District Hospital, Sop Moei

95000

Malaria Clinic, Mueang

95120

District Hospital, Ka Bang

95130

District Hospital, Bannang Sata

Malaria Clinic, Bannang Sata

95150

District Hospital, Than To

Malaria Clinic, Than To

All Listed Sponsors
collaborator

Medicines for Malaria Venture

OTHER

lead

Dr. Prayuth Sudathip

OTHER_GOV